Talking Things Pharmacists Need to Know About Urine Drug Monitoring | Locked On Pharmacy

Controlled substances, including opioids, benzodiazepines, and medical cannabis, are commonly prescribed for the treatment of chronic pain. Urine drug screens (UDS) are often used in clinical practice to test for the presence of prescribed drugs to monitor compliance. Understanding how to appropriately interpret the results of urine drug screening is critical to providing effective patient care and maintaining patient trust. Pharmacists in various practice settings can play important roles in urine drug screenings.

The goal of this podcast is to provide pharmacists and other clinicians with insight and information for appropriately interpreting urine drug screening results. The conversation will focus on the types of drug screening panels, possible causes of false- positives and negatives, and how metabolism of drugs can impact urine drug screening results. Tips on how to effectively have conversations with patients that can be difficult will also be part of the discussion.

This activity is supported by a grant from the Providers Clinical Support System (PCSS).
Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.